Home / All Categories / Medical Care / Global Amyotrophic Lateral Sclerosis Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Global Amyotrophic Lateral Sclerosis Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Global Amyotrophic Lateral Sclerosis Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Pages: 100      Published Date: Mar 2019       Category: Medical Care
Amyotrophic lateral sclerosis is a neurodegenerative disease. ALS affects the nerve cells in the brain and spinal cord that control the voluntary muscles. It is also known as the Lou Gehrig’s disease. Amyotrophic lateral sclerosis can be caused due to various factors such as genetics or environmental factors such as exposure to toxic or infectious agents, viruses, physical trauma, diet, and behavioral and occupational factors.

Scope of the Report:
The global Amyotrophic Lateral Sclerosis Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Amyotrophic Lateral Sclerosis Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Amyotrophic Lateral Sclerosis Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Amyotrophic Lateral Sclerosis Drugs market by product type and applications/end industries.

Market Segment by Companies, this report covers
    Sanofi
    Mitsubishi Tanabe Pharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
    Edaravone
    Riluzole
    Others

Market Segment by Applications, can be divided into
    Hospitals
    Clinics
    Ambulatory Surgical Centers
    Others
Table of Contents

1 Amyotrophic Lateral Sclerosis Drugs Market Overview
    1.1 Product Overview and Scope of Amyotrophic Lateral Sclerosis Drugs
    1.2 Classification of Amyotrophic Lateral Sclerosis Drugs by Types
        1.2.1 Global Amyotrophic Lateral Sclerosis Drugs Revenue Comparison by Types (2019-2024)
        1.2.2 Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Types in 2018
        1.2.3 Edaravone
        1.2.4 Riluzole
        1.2.5 Others
    1.3 Global Amyotrophic Lateral Sclerosis Drugs Market by Application
        1.3.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size and Market Share Comparison by Applications (2014-2024)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Ambulatory Surgical Centers
        1.3.5 Others
    1.4 Global Amyotrophic Lateral Sclerosis Drugs Market by Regions
        1.4.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
        1.4.1 North America (USA, Canada and Mexico) Amyotrophic Lateral Sclerosis Drugs Status and Prospect (2014-2024)
        1.4.2 Europe (Germany, France, UK, Russia and Italy) Amyotrophic Lateral Sclerosis Drugs Status and Prospect (2014-2024)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Amyotrophic Lateral Sclerosis Drugs Status and Prospect (2014-2024)
        1.4.4 South America (Brazil, Argentina, Colombia) Amyotrophic Lateral Sclerosis Drugs Status and Prospect (2014-2024)
        1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Amyotrophic Lateral Sclerosis Drugs Status and Prospect (2014-2024)
    1.5 Global Market Size of Amyotrophic Lateral Sclerosis Drugs (2014-2024)
2 Manufacturers Profiles
    2.1 Sanofi
        2.1.1 Business Overview
        2.1.2 Amyotrophic Lateral Sclerosis Drugs Type and Applications
            2.1.2.1 Product A
            2.1.2.2 Product B
        2.1.3 Sanofi Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2017-2018)
    2.2 Mitsubishi Tanabe Pharma
        2.2.1 Business Overview
        2.2.2 Amyotrophic Lateral Sclerosis Drugs Type and Applications
            2.2.2.1 Product A
            2.2.2.2 Product B
        2.2.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Amyotrophic Lateral Sclerosis Drugs Market Competition, by Players
    3.1 Global Amyotrophic Lateral Sclerosis Drugs Revenue and Share by Players (2014-2019)
    3.2 Market Concentration Rate
        3.2.1 Top 5 Amyotrophic Lateral Sclerosis Drugs Players Market Share
        3.2.2 Top 10 Amyotrophic Lateral Sclerosis Drugs Players Market Share
    3.3 Market Competition Trend
4 Global Amyotrophic Lateral Sclerosis Drugs Market Size by Regions
    4.1 Global Amyotrophic Lateral Sclerosis Drugs Revenue and Market Share by Regions
    4.2 North America Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    4.3 Europe Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    4.4 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    4.5 South America Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    4.6 Middle East and Africa Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
5 North America Amyotrophic Lateral Sclerosis Drugs Revenue by Countries
    5.1 North America Amyotrophic Lateral Sclerosis Drugs Revenue by Countries (2014-2019)
    5.2 USA Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    5.3 Canada Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    5.4 Mexico Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
6 Europe Amyotrophic Lateral Sclerosis Drugs Revenue by Countries
    6.1 Europe Amyotrophic Lateral Sclerosis Drugs Revenue by Countries (2014-2019)
    6.2 Germany Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    6.3 UK Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    6.4 France Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    6.5 Russia Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    6.6 Italy Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Revenue by Countries
    7.1 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Revenue by Countries (2014-2019)
    7.2 China Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    7.3 Japan Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    7.4 Korea Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    7.5 India Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    7.6 Southeast Asia Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
8 South America Amyotrophic Lateral Sclerosis Drugs Revenue by Countries
    8.1 South America Amyotrophic Lateral Sclerosis Drugs Revenue by Countries (2014-2019)
    8.2 Brazil Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    8.3 Argentina Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    8.4 Colombia Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Amyotrophic Lateral Sclerosis Drugs by Countries
    9.1 Middle East and Africa Amyotrophic Lateral Sclerosis Drugs Revenue by Countries (2014-2019)
    9.2 Saudi Arabia Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    9.3 UAE Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    9.4 Egypt Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    9.5 Nigeria Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
    9.6 South Africa Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
10 Global Amyotrophic Lateral Sclerosis Drugs Market Segment by Type
    10.1 Global Amyotrophic Lateral Sclerosis Drugs Revenue and Market Share by Type (2014-2019)
    10.2 Global Amyotrophic Lateral Sclerosis Drugs Market Forecast by Type (2019-2024)
    10.3 Edaravone Revenue Growth Rate (2014-2024)
    10.4 Riluzole Revenue Growth Rate (2014-2024)
    10.5 Others Revenue Growth Rate (2014-2024)
11 Global Amyotrophic Lateral Sclerosis Drugs Market Segment by Application
    11.1 Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Application (2014-2019)
    11.2 Amyotrophic Lateral Sclerosis Drugs Market Forecast by Application (2019-2024)
    11.3 Hospitals Revenue Growth (2014-2019)
    11.4 Clinics Revenue Growth (2014-2019)
    11.5 Ambulatory Surgical Centers Revenue Growth (2014-2019)
    11.6 Others Revenue Growth (2014-2019)
12 Global Amyotrophic Lateral Sclerosis Drugs Market Size Forecast (2019-2024)
    12.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size Forecast (2019-2024)
    12.2 Global Amyotrophic Lateral Sclerosis Drugs Market Forecast by Regions (2019-2024)
    12.3 North America Amyotrophic Lateral Sclerosis Drugs Revenue Market Forecast (2019-2024)
    12.4 Europe Amyotrophic Lateral Sclerosis Drugs Revenue Market Forecast (2019-2024)
    12.5 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Revenue Market Forecast (2019-2024)
    12.6 South America Amyotrophic Lateral Sclerosis Drugs Revenue Market Forecast (2019-2024)
    12.7 Middle East and Africa Amyotrophic Lateral Sclerosis Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Data Source
List of Tables and Figures

Figure Amyotrophic Lateral Sclerosis Drugs Picture
Table Product Specifications of Amyotrophic Lateral Sclerosis Drugs
Table Global Amyotrophic Lateral Sclerosis Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Types in 2018
Figure Edaravone Picture
Figure Riluzole Picture
Figure Others Picture
Table Global Amyotrophic Lateral Sclerosis Drugs Revenue (Million USD) by Application (2014-2024)
Figure Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Ambulatory Surgical Centers Picture
Figure Others Picture
Table Global Market Amyotrophic Lateral Sclerosis Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Amyotrophic Lateral Sclerosis Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Amyotrophic Lateral Sclerosis Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Amyotrophic Lateral Sclerosis Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Amyotrophic Lateral Sclerosis Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Amyotrophic Lateral Sclerosis Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Amyotrophic Lateral Sclerosis Drugs Type and Applications
Table Sanofi Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Type and Applications
Table Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Amyotrophic Lateral Sclerosis Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Amyotrophic Lateral Sclerosis Drugs Revenue Share by Players (2014-2019)
Figure Global Amyotrophic Lateral Sclerosis Drugs Revenue Share by Players in 2017
Figure Global Amyotrophic Lateral Sclerosis Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Amyotrophic Lateral Sclerosis Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Amyotrophic Lateral Sclerosis Drugs Revenue Market Share in 2018
Figure Global Amyotrophic Lateral Sclerosis Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Amyotrophic Lateral Sclerosis Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Regions in 2018
Figure North America Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure South America Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Table North America Amyotrophic Lateral Sclerosis Drugs Revenue by Countries (2014-2019)
Table North America Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Countries in 2018
Figure USA Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Table Europe Amyotrophic Lateral Sclerosis Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Countries in 2018
Figure Germany Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure UK Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure France Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Countries in 2018
Figure China Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure India Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Table South America Amyotrophic Lateral Sclerosis Drugs Revenue by Countries (2014-2019)
Table South America Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Countries in 2018
Figure Brazil Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Amyotrophic Lateral Sclerosis Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Amyotrophic Lateral Sclerosis Drugs Revenue and Growth Rate (2014-2019)
Table Global Amyotrophic Lateral Sclerosis Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Amyotrophic Lateral Sclerosis Drugs Revenue Share by Type (2014-2019)
Figure Global Amyotrophic Lateral Sclerosis Drugs Revenue Share by Type (2014-2019)
Figure Global Amyotrophic Lateral Sclerosis Drugs Revenue Share by Type in 2019
Table Global Amyotrophic Lateral Sclerosis Drugs Revenue Forecast by Type (2019-2024)
Figure Global Amyotrophic Lateral Sclerosis Drugs Market Share Forecast by Type (2019-2024)
Figure Global Edaravone Revenue Growth Rate (2014-2019)
Figure Global Riluzole Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Amyotrophic Lateral Sclerosis Drugs Revenue by Application (2014-2019)
Table Global Amyotrophic Lateral Sclerosis Drugs Revenue Share by Application (2014-2019)
Figure Global Amyotrophic Lateral Sclerosis Drugs Revenue Share by Application (2014-2019)
Figure Global Amyotrophic Lateral Sclerosis Drugs Revenue Share by Application in 2019
Table Global Amyotrophic Lateral Sclerosis Drugs Revenue Forecast by Application (2019-2024)
Figure Global Amyotrophic Lateral Sclerosis Drugs Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Amyotrophic Lateral Sclerosis Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Amyotrophic Lateral Sclerosis Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Amyotrophic Lateral Sclerosis Drugs Revenue Market Forecast (2019-2024)
Figure Europe Amyotrophic Lateral Sclerosis Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Revenue Market Forecast (2019-2024)
Figure South America Amyotrophic Lateral Sclerosis Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Amyotrophic Lateral Sclerosis Drugs Revenue Market Forecast (2019-2024)
Sanofi
Mitsubishi Tanabe Pharma
Request Sample
If you need any reports sample, just let us know
Full Name: *
Email Address: *
Country: *
Phone Number: *
Channel: *
Other:
Request Message: *
Verification Code: *
 
We aim to respond to all request on the same business day.

Purchase this Market Research Report

Single User License 3480.00 USD
Multi User License 5220.00 USD
Corporate Users License 6960.00 USD
Add to Cart Buy Now
goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico